Alfasigma S.p.a.

This study follows over 1,300 adults with moderate to severe rheumatoid arthritis who are taking filgotinib medication. Researchers are observing how well the drug controls symptoms, how long patients stay on it, and what side effects occur in everyday practice. The goal is to un…

This study is observing adults in France with moderate to severe rheumatoid arthritis who are starting treatment with the drug filgotinib. Researchers will follow 155 patients for two years to see how well the drug controls their disease, how safe it is, and how it affects their …

This study is testing whether daily filgotinib pills can help control active axial spondyloarthritis, a chronic inflammatory disease that causes back pain and stiffness. It will compare a 200mg dose, a 100mg dose, and a placebo pill in 495 adults who haven't gotten enough relief …

This study is observing how well the drug filgotinib works and how safe it is for adults with moderate to severe ulcerative colitis in everyday medical practice. It will follow 509 patients for up to two years to see how long they stay on the treatment and if it improves their sy…